All Posts

Biotech Catalyst Watchlist Jan 15th 2022

Last week we saw a number of buyouts and had the JP Morgan conference. As we move through this quarter we see a number of PDUFA events...

Jan 13, 20232 min read

See Table 1 for all Stock Market Holidays where the NASDAQ stock market is closed. Table 1. Stock market holidays in 2023 If you are...

Jan 12, 20231 min read

Last updated 1/12/2023 Summary: MDGL read out Phase 3 topline data on December 19, leading to a stock move of over +250%! Many other NASH...

Jan 11, 20233 min read

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Jan 6, 20231 min read

We ended the previous week with the FDA approval for Lecanemab treating Alzheimer's. We'll track and share the future events as they...

Jan 6, 20232 min read

We ended the previous week with the FDA approval for Lecanemab treating Alzheimer's. We'll track and share the future events as they...

Jan 6, 20232 min read

Summary: The biotech sector saw many exciting events and readouts in 2022 While smid-cap biopharmas were down more than 20% during 2022,...

Jan 6, 20233 min read

Summary: Biogen and Eisai's asset Lecanemab has a PDUFA date set for Friday 1/6/23 Lecanemab targets and effectively reduces beta-amyloid...

Jan 4, 20235 min read

AUPH PR on settlement of patent disputes with the Indian generic company, Sun is very brief. See entire substantive portion of press...

Jan 3, 20233 min read

Last week we saw the TGTX get approval and the stock is up 50%. As we set our sights on January there's lot to be on the lookout for. We...

Dec 30, 20221 min read

Our platform helps you uncover your next biotech investment opportunity